Dr Xiangjian Zheng is the head of Lab of Cardiovascular Signalling at Centenary Institute and a member of Faculty of Medicine. His current research focuses on molecular mechanisms of cardiovascular development and diseases.
He obtained his Ph.D in Molecular Medicine from Medical College of Georgia, where he studied lipid signalling in skin biology and endocrine control of blood pressure control. Zheng continued on his research in lipid signalling as a research fellow in Department of Pharmacology at Vanderbilt University School of Medicine. He used the combination of zebrafish model and lipidomics approaches to investigated lipid-mediated signalling in angiogenesis and cancer biology. After joined Penn Cardiovascular Institute at Perelman School of Medicine at University of Pennsylvania, Zheng’s research became more focused on human vascular diseases.
Learn more about his Research Laboratory.